Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

(2022) Zhen Cui et al.   CELL

Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2

(2022) Hongjie Xia et al.   Cell Host & Microbe

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity

(2022) Bo Meng et al.   NATURE

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

(2022) Huiping Shuai et al.   NATURE

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

(2022) Rigel Suzuki et al.   NATURE

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

(2022) Yunlong Cao et al.   NATURE

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

(2022) Lihong Liu et al.   NATURE

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

(2022) Henning Gruell et al.   NATURE MEDICINE

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection

(2022) Jing Zou et al.   Nature Communications

Cryo-EM structure of the SARS-CoV-2 Omicron spike

(2022) Gabriele Cerutti et al.   Cell Reports

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

(2022) Daichi Yamasoba et al.   CELL

Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2

(2022) John P. Evans et al.   Cell Host & Microbe

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

(2022) Sho Iketani et al.   NATURE

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar

(2022) Laith J. Abu-Raddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

(2022) Jingyou Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529

(2022) Qian Wang et al.   Cell Reports

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

(2022) Aekkachai Tuekprakhon et al.   CELL

Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters

(2022) Wen Su et al.   JOURNAL OF INFECTIOUS DISEASES

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

(2022) Qian Wang et al.   NATURE

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

(2022) Yunlong Cao et al.   NATURE

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants

(2022) Panke Qu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5

(2022) Nicole P. Hachmann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine

(2022) Chaitanya Kurhade et al.   Nature Communications

Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection

(2022) Khadija Khan et al.   Nature Communications

Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5

(2022) Izumi Kimura et al.   CELL

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant

(2022) Akatsuki Saito et al.   Cell Host & Microbe

Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75

(2022) Yunlong Cao et al.   Cell Host & Microbe

Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant

(2022) Panke Qu et al.   Cell Host & Microbe

Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75

(2022) Qian Wang et al.   Cell Host & Microbe

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype

(2022) G. Tuba Barut et al.   Nature Communications

Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark

(2022) Frederik Plesner Lyngse et al.   Nature Communications

Covid-19: Hospital admissions rise in England as some trusts reinstate mask requirements

(2022) Gareth Iacobucci   BMJ-British Medical Journal

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

(2021) Allison J. Greaney et al.   Nature Communications

Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H

(2021) Cong Zeng et al.   mBio

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

(2020) David E. Gordon et al.   NATURE

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

(2020) Leonid Yurkovetskiy et al.   CELL

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

(2020) Christopher O. Barnes et al.   NATURE

Spike mutation D614G alters SARS-CoV-2 fitness

(2020) Jessica A. Plante et al.   NATURE

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors

(2020) Cong Zeng et al.   JCI Insight

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

(2020) Drew Weissman et al.   Cell Host & Microbe

Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective

(2010) Nicolas Guex et al.   ELECTROPHORESIS

Quantitative Comparison of HTLV-1 and HIV-1 Cell-to-Cell Infection with New Replication Dependent Vectors

(2010) Dmitriy Mazurov et al.   PLoS Pathogens